The Retina Foundation of the Southwest – a medical research organization committed to vision loss prevention and sight restoration – named the Still Water Foundation as the 2023 Hunt Family Award recipient for supporting innovative solutions for retinal disease treatment.
The Still Water Foundation funded transformational research of an ocular drug delivery device that provides an effective and low-risk treatment for patients living with age-related macular degeneration (AMD). The device is placed in the surface tissue of the eye and the medicine is delivered in a slow-release manner for up to a year. It serves as an optimal non-invasive method that reduces the number of clinic visits per year and can be removed easily.
“The Still Water Foundation has been a crucial partner in funding research and patents to accelerate treatment efforts. They recognize the challenges many are facing due to vision loss and seek breakthrough solutions,” said Karl Csaky, chief executive and medical officer of the Retina Foundation. “At the Retina Foundation, we are positioned to make a significant impact on population health through our research-based, patient-centered and expedited approach.”
Based in Austin, the Still Water Foundation’s mission is to promote global well-being through its high-impact philanthropy in the areas of education, the arts, the environment and partnering with rural Texas communities.
“We are honored to receive the Hunt Family Visionary Award, named after a family with a long tradition of philanthropy, much like our own legacy at Still Water Foundation. Research from the Retina Foundation has and will continue to improve the quality of life for those battling retinal diseases. Our support of the Foundation’s ocular drug delivery device will provide millions of Americans with a therapeutic drug for AMD treatment,” said Ellen Ray, CEO of the Still Water Foundation.
The annual Visionary Luncheon will take place May 18, celebrating the Foundation’s mission to preserve and restore sight and recognizing those who have taken monumental steps to support the latest innovations that improve patients’ quality of life.
